Company: PHAT
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034183
Chunk: 257

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 1B
Chunk 257
---
4

    December 31,2023

    Assets

    Current assets:

    Cash and cash equivalents
     
    $
    297,263

    $
    381,393

    Prepaid expenses and other current assets

    20,866

    13,194

    Accounts receivable, net

    38,797

    1,637

    Inventory

    3,208

    1,208

    Total current assets

    360,134

    397,432

    Property and equipment, net

    1,476

    2,146

    Operating lease right-of-use assets

    613

    1,475

    Restricted cash

    2,862

    2,863

    Inventory, non-current

    11,540

    8,234

    Other long-term assets

    1,693

    1,692

    Total assets
     
    $
    378,318

    $
    413,842

    Liabilities and Stockholders’ Deficit

    Current liabilities:

    Accounts payable
     
    $
    10,507

    $
    12,601

    Accrued expenses

    53,232

    17,197

    Accrued interest

    1,711

    1,146

    Operating lease liabilities, current

    501

    726

    Current portion of revenue interest financing liability

    19,777

    7,111

    Total current liabilities

    85,728

    38,781

    Long-term debt, net of discount

    201,409

    137,842

    Revenue interest financing liability

    333,261

    299,816

    Operating lease liabilities

    —

    462

    Other long-term liabilities

    11,500

    9,700

    Total liabilities

    631,898

    486,601

    Commitments and contingencies (Note 3)

    Stockholders’ deficit:

    Preferred stock, $0.0001 par value; authorized shares — 40,000,000 at December 31, 2024 and December 31, 2023; no shares issued and outstanding at December 31, 2024 and December 31, 2023